Common questions

Is Pantheon Resources a good investment?

Is Pantheon Resources a good investment?

Pantheon Resources has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Is Blue Prism stock a buy?

We would prefer less top line growth and more profitable growth,’ the Canaccord analyst said. The broker has Blue Prism shares rated as a ‘speculative buy’ with a price target of £12.50….Fallers.

Company Price % Chg
Moonpig Group PLC 340.40 -5.55
Just Group PLC 89.75 -5.38
Firstgroup PLC 89.10 -5.06

Is MaxCyte a good investment?

If you are looking for stocks with good return, MaxCyte Inc can be a profitable investment option. With a 5-year investment, the revenue is expected to be around +372.77%.

Can you trade on Advfn?

Trade without compromise on a premium platform without premium prices – trade UK/US stocks with a flat fee of £2.95/$3.95, with no hidden charges, no custody or deposit fees, no minimum deposit needed, no inactivity charges. Open account and get 100 welcome free trades. All trading involved risks.

Does Blue Prism pay dividends?

Blue Prism’s Dividends Dividends made by Blue Prism from their annual profits to their shareholders are shown here – normally on an interim and annual basis.

Is Blue Prism profitable?

Blue Prism Group isn’t currently profitable, so most analysts would look to revenue growth to get an idea of how fast the underlying business is growing. Shareholders of unprofitable companies usually expect strong revenue growth. In the last 5 years Blue Prism Group saw its revenue grow at 54% per year.

Is MaxCyte a buy?

MaxCyte has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Is Advfn free?

Incredible array of trading & investment tools ADVFN provides full real time live streaming prices for LSE & AIM stocks and a suite of professional grade charting and analysis tools, completely free. Joining ADVFN is free of charge – you don’t have to pay a penny to start using our free investment tools.

How do I delete my Advfn account?

Please give us a call on 020 3879 4460 or send notice of your wish to terminate or downgrade your subscription to ADVFN PLC, Subs Dept, Suite 27 Essex Technology Centre, The Gables, Fyfield Road, Ongar, Essex, CM5 0GA.

What can you do on the ADVFN discussion forum?

Discuss your stocks, read research and gauge opinion from thousands of other full and part time investors. Any and every stock is open for discussion, with active posters contributing information and research that you would struggle to put together on your own.

What kind of company is Agenus Inc.?

Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer).

What are the products that Agenus is developing?

The company also has various product candidates under development, which include QS-21 Stimulon adjuvant, which is in Phase III clinical trials for the treatment of non-small cell lung cancer, melanoma, malaria, and singles, as well as in Phase II clinical trials for the treatment of Alzheimer’s disease.

When did Antigenics change its name to Agenus?

The company was formerly known as Antigenics Inc. and changed its name in January, 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Share this post